Sales of edibles, vape pens and other marijuana gifts spiked on the Wednesday before Thanksgiving last year and as retailers increasingly promote it as an unofficial shopping holiday ahead of Black Friday, Small Business Saturday and Cyber Monday. » Read More
By: Bertha Coombs
The Florida lawsuit accuses the drug stores and pharmaceutical distributors of playing as big a role in the proliferation of opioid addiction as the drug manufacturers of OxyContin and fentanyl, a synthetic opioid 50 times stronger than heroin. » Read More |
By: Angelica LaVito
Pfizer deferred planned drug price increases this summer after President Donald Trump criticized the drug giant on Twitter. » Read More |
By: Meg Tirrell
BioMarin's clinical trial of a gene therapy for hemophilia is providing hope to patients with the disease. It is an experimental treatment that uses a virus to deliver a healthy copy of a gene to make up for one that causes excessive bleeding. » Read More |
A Twitter exchange led to Cuban's fund, Radical Investments, putting $250,000 into Perlara's $7.4 million fundraising round. Now, Cuban's investing again to find treatments for an extremely rare disease called Leigh syndrome.
Jim Cramer reveals how Bausch Health has put together an amazing comeback.
Marijuana producer Tilray reported quarterly earnings that beat analysts' expectations on Tuesday, though total revenues fell just shy of estimates.
Amarin CEO is defending results from a major clinical trial of its Vascepa heart drug after researchers raise questions about early results that sent stocks up in September.
Aurora Cannabis reported on Monday that revenue jumped 260 percent over the last 12 months, with kilograms produced climbing to 4,996 from 1,010 over the past year.
Jim Cramer explains how a strong consumer snapshot could force an ugly reaction from the Fed.
Investors should concentrate and then capitalize on the year-end bounce in technology stocks, Fundstrat technical strategist Robert Sluymer says.
Health care was the top issue for Americans voting in Tuesday's midterm elections.
Health care was the top issue for Americans voting in Tuesday's midterm elections.
President Trump says at a White House press conference he hopes to work with congressional Democrats on issues ranging from infrastructure to drug pricing.
The midterm election results are a win for the marijuana industry, according to the CEO of a prominent cannabis company.
Rep. Chris Collins, the Republican recently indicted on federal insider trading charges, will retain his House seat representing New York's 27th District.
Michigan voters authorize the legalization of possession, use and cultivation of marijuana products by those at least 21 years old.
The flu vaccine isn't perfect, but it's still the best way to protect yourself and others from influenza.
Jim Cramer warns investors not to panic in the wake of Apple's earnings.
Jim Cramer hears from GW Pharmaceuticals CEO Justin Gover about his company's cannabis-based epilepsy treatment that just launched in the United States.
Get the best of CNBC in your inbox
Data also provided by 
